Drug
Insulin Icodec
Insulin Icodec: highest development phase Phase 3, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| Insulin Icodec NCT05813912 | Phase 3 | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Insulin Icodec on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.